Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Ultrasound, Washington University in St. Louis, St. Louis, MO (Dr Rimsza).
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, University of Alabama Birmingham, Birmingham, AL (Dr Perez).
Am J Obstet Gynecol MFM. 2021 Sep;3(5):100402. doi: 10.1016/j.ajogmf.2021.100402. Epub 2021 May 25.
The national epidemic of opioid misuse has focused its attention on postpartum analgesic usage. Adequate pain control achieved with nonopioid pain medications and conservative measures could reduce the number of opioid pain medications available for misuse and diversion. Interventions that decrease inpatient opioid use after delivery could reduce the potential for chronic dependence in postpartum women. Modification of preloaded electronic order sets to decrease opioid administration has successfully reduced opioid use following a major abdominal surgery, including cesarean delivery. However, interventions to reduce opioid use following vaginal delivery are not well described.
We aimed to evaluate the effect of removing opioid medications from postpartum order sets on medication usage following vaginal delivery.
We performed a retrospective cohort study of women undergoing a singleton vaginal delivery at an academic tertiary care center. Our institution removed opioid medications from postpartum order sets in April 2018. We compared the following 2 delivery cohorts: the "preintervention" cohort (April 2016-March 2018) and the "postintervention" cohort (June 2018-July 2018). The primary outcome was postpartum opioid use. The secondary outcomes were nonopioid analgesic use and discharge with an opioid prescription. We compared the demographic and obstetrical data, self-reported pain scores, and postpartum analgesic usage between groups. We determined that a minimum of 138 patients would be needed in each group to identify a 20% decrease in opioid usage (α=.05; β=.2).
We analyzed 276 subjects: 138 in the preintervention group and 138 in the postintervention group. The postintervention group was older and more likely to have an operative vaginal delivery. Otherwise, groups had similar demographic and obstetrical characteristics. Postpartum opioid use decreased from 56% in the preintervention group to 16% in the postintervention group, a 71% reduction (P<.001). The incidence of severe pain score (>7) was similar between groups with a median occurrence of 1 (interquartile range, 0-4) for both (P=.7). The number of opioid discharge prescriptions among those receiving inpatient opioids was significantly lower in the postintervention group than in the preintervention group (18% vs 38%, respectively), a 53% decrease (P<.001).
Removal of opioids from the postpartum order set was associated with lower rates of opiate usage following vaginal delivery in a single center without changing the frequency of severe pain scores. This simple intervention has the potential to reduce opioid exposure.
全国阿片类药物滥用的流行情况使得人们开始关注产后镇痛药物的使用情况。通过使用非阿片类镇痛药物和保守措施来充分控制疼痛,可以减少可用于滥用和转移的阿片类药物数量。减少产后住院期间阿片类药物使用的干预措施可以降低产后妇女慢性依赖的可能性。修改预加载的电子医嘱集以减少阿片类药物的使用,已经成功减少了主要腹部手术后(包括剖宫产)的阿片类药物使用。然而,减少阴道分娩后阿片类药物使用的干预措施并没有得到很好的描述。
评估从产后医嘱集中去除阿片类药物对阴道分娩后药物使用的影响。
我们对在学术型三级保健中心接受单胎阴道分娩的妇女进行了回顾性队列研究。我们的机构在 2018 年 4 月从产后医嘱集中去除了阿片类药物。我们比较了以下两个分娩队列:“干预前”队列(2016 年 4 月至 2018 年 3 月)和“干预后”队列(2018 年 6 月至 2018 年 7 月)。主要结局是产后阿片类药物的使用情况。次要结局是使用非阿片类镇痛药和出院时开阿片类药物。我们比较了两组之间的人口统计学和产科数据、自我报告的疼痛评分和产后镇痛药物的使用情况。我们确定,每组需要至少 138 例患者,才能确定阿片类药物使用率降低 20%(α=.05;β=.2)。
我们分析了 276 名受试者:干预前组 138 名,干预后组 138 名。干预后组年龄较大,且更有可能进行阴道助产。除此之外,两组的人口统计学和产科特征相似。与干预前组的 56%相比,干预后组的产后阿片类药物使用率降至 16%,降低了 71%(P<.001)。两组的严重疼痛评分(>7)发生率相似,中位数均为 1(四分位距,0-4)(P=.7)。在接受住院阿片类药物的患者中,开阿片类药物出院的人数在干预后组显著低于干预前组(分别为 18%和 38%),降低了 53%(P<.001)。
在不改变严重疼痛评分频率的情况下,从产后医嘱集中去除阿片类药物与阴道分娩后阿片类药物使用率降低有关。这种简单的干预措施有可能减少阿片类药物的暴露。